Telehealth and Digital Therapeutics for Treatment of Alcohol Use Disorders during the COVID-19 Pandemic and Beyond

By Jamie Bartlett

Posted October 28, 2021

Calendar

When:

November 3, 2021 @ 10:00 am

2021-11-03T10:00:00-07:00

2021-11-03T10:15:00-07:00

Where:

Virtual Event

Cost:

Free

Contact:

Friends of NIAAA

Event website

Webinar on Telehealth and Digital Therapeutics for Treatment of Alcohol Use Disorders during the COVID-19 Pandemic and Beyond

The COVID-19 pandemic is having an enormous impact on public health and well being. Alcohol misuse, a significant public health concern, has the potential to further complicate the pandemic. Alcohol misuse may influence COVID-19 susceptibility and severity and has been shown to contribute to alcohol misuse. The National Institute on Alcohol Abuse and Alcoholism (NIAAA), one of the 27 Institutes and Centers of the National Institutes of Health, is supporting research on the interaction of alcohol with the pandemic and on how the treatment system has responded. This webinar will focus on how treatments for the full spectrum of alcohol use disorders have been adapted to COVID-19 mitigation efforts—in particular the use of tele-health and digital therapeutics—and discuss what elements of these eHealth interventions should remain once the pandemic is under control.

This webinar is sponsored by the Friends of NIAAA and moderated by Robert B. Huebner, Ph.D, Chair of Friends of NIAAA.

Speakers

George Koob, Ph.D, Director, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
George F. Koob, Ph.D., is an internationally-recognized expert on alcohol and stress, and the neurobiology of alcohol and drug addiction. He is the Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), where he provides leadership in the national effort to reduce the public health burden associated with alcohol misuse. As NIAAA Director, Dr. Koob oversees a broad portfolio of alcohol research ranging from basic science to epidemiology, diagnostics, prevention, and treatment.

Haiden A. Huskamp, PhD, Henry J. Kaiser Professor of Health Care Policy, Harvard Medical School

Haiden Huskamp, Ph.D., is a health economist and the Henry J. Kaiser Professor of Health Care Policy. Dr. Huskamp has three primary areas of research: 1) mental health and substance use disorder policy; 2) prescription drug policy; and 3) the financing and utilization of end-of-life care services. She also serves as Director of Harvard’s National Institute of Mental Health (NIMH) T32 Pre- and Post-doctoral Training Program in Mental Health Policy. Dr. Huskamp is Multi-Principal Investigator (MPI) on an R01 funded by the National Institute on Drug Abuse (NIDA) assessing the use of telemedicine for the treatment of opioid use disorder.

Stacy Sterling, DrPH, MSW, MPH, Research Scientist, Kaiser Permanente Northern California

Stacy Sterling, DrPH, MSW, MPH, is with the Drug and Alcohol Research Team (DART) and the Behavioral Health Research Initiative. She received her doctoral training at the University of North Carolina Gillings School of Global Public Health, and her Master’s degrees in Public Health and Social Welfare at the University of California, Berkeley. Her research interests include developing systems for implementing evidence-based, integrated, behavioral health services into primary care, adolescent behavioral health prevention and early intervention, and alcohol and drug and mental health treatment outcomes and access.

William Campbell Ph.D., Clinical Director, Science Division, CheckUp & Choices

Dr. William Campbell serves as the Clinical Director for CheckUp & Choices and Principal Investigator on new research projects. He’s been developing web-based interventions for alcohol and drug problems for over ten years. William is passionate about helping people cultivate their well-being, especially through technology. Through CheckUp & Choices, William hopes to significantly expand the effectiveness of both new and traditional therapies. William received his PhD in clinical psychology from the University of New Mexico.

Douglas Novins, MD, Cannon Y. & Lyndia Harvey Chair in Child and Adolescent Psychiatry, University of Colorado, Anchutz Medical Campus

Dr. Novins serves as the Cannon Y. & Lyndia Harvey Chair in Child and Adolescent Psychiatry, Chair, Pediatric Mental Health Institute, Children’s Hospital Colorado, Professor, Vice Chair, & Director, Division of Child & Adolescent Psychiatry, Department of Psychiatry, University of Colorado School of Medicine, and Professor of Community & Behavioral Health, Centers for American Indian & Alaska Native Health, Colorado School of Public Health.

Robert B. Huebner, PhD, Chair, Friends of NIAAA

Robert B. Huebner, PhD played a leadership role in treatment and recovery research at the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for over two decades. Bob was recruited to move to Washington in 1986 to lead a project on homelessness commissioned by the Senate Labor and Human Resources Committee. He then joined NIAAA in 1988 and fostered the growth of NIAAA’s research portfolio focused on behavioral treatments and health services research. He is a licensed psychologist in the District of Columbia. Bob is deeply committed to the idea that treatment for alcohol use disorders should be accessible, attractive, effective, reasonably priced, and tailored to individual needs and preferences.